Status
Conditions
Treatments
About
Mechanical low back pain (LBP) stems from spinal structures or surrounding tissues, often caused by overuse or trauma, and is prevalent globally with high recurrence rates. Key contributing factors include biomechanical, psychological, and social elements. The latissimus dorsi (LD), along with other back muscles, plays a crucial role in lumbar stability via the thoracolumbar fascia. Stretching the LD has shown positive effects in reducing pain and improving function in chronic LBP patients. Physical therapy treatments include manual therapy, core stabilization, and flexibility exercises. Muscle Energy Techniques (MET), particularly targeting the LD, can enhance flexibility and spinal mobility when applied correctly.
Full description
Mechanical low back pain (MLBP) originates from structural components of the spine, such as intervertebral discs, muscles, ligaments, or joints, and is commonly caused by repetitive trauma, poor posture, or overuse. It is a leading cause of functional disability worldwide, with high recurrence rates. Physiotherapy plays a central role in managing MLBP by addressing contributing biological, psychological, and social factors. The latissimus dorsi (LD) muscle, due to its anatomical connection with the pelvis via the thoracolumbar fascia (TLF), significantly influences lumbar stability. Impaired extensibility or overactivity of the LD can contribute to mechanical dysfunction. Incorporating LD stretching into rehabilitation protocols has shown enhanced outcomes in pain reduction and functional improvement. Muscle Energy Techniques (MET), particularly Post Facilitation Stretching, utilize controlled muscle contractions to improve flexibility and relieve tension in shortened muscles. Proper application of MET targeting the LD has demonstrated effectiveness in increasing range of motion and supporting spinal stability in patients with chronic low back pain.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups
Loading...
Central trial contact
Laraib Khurshid, DPT
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal